Safety and Efficacy of a Glaucoma Drug Delivery System

Completed · Phase 2 · Has a placebo group

Conditions studied: Glaucoma, Open-Angle, Ocular Hypertension

In brief

The purpose of this study is to evaluate the ocular safety and efficacy of a glaucoma drug delivery system in open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT00824720

Run by

Vistakon Pharmaceuticals

People needed

55

Starts

2008-12-01

Expected to finish

2009-04-01

Last updated by the study team

2015-03-06

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Man or woman 21 years of age or greater
• must have open angle glaucoma or ocular hypertension.
• Corrected visual acuity in each eye of 20/200 or better.

You may not qualify if…

• Previous glaucoma intraocular surgery or refractive surgery.
• Planned contact lens use during the study.
• Clinically significant ocular or systemic disease that might interfere with the study.
• Use of chronic corticosteroids by any route.

Where it is running

• Study site — Artesia, California, United States
• Study site — Louisville, Kentucky, United States
• Study site — Baltimore, Maryland, United States
• Study site — Mt. Pleasant, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.